Normal view MARC view ISBD view

Establishment of stability-indicating purity method based on the stress degradation behaviour of human glucagon-like peptide-1 analog liraglutide using reverse phase-liquid chromatography

By: Giri, T.
Contributor(s): Kukreja, Divya.
Publisher: Mumbai Indian Journal of Pharmaceutical Science 2023Edition: Vol.85(4), Jul-Aug.Description: 1068-1076p.Subject(s): PHARMACEUTICSOnline resources: Click here In: Indian journal of pharmaceutical sciencesSummary: Method development for synthetic peptide molecules is often a challenging task as peptides get easily degraded in mild stress conditions and also offer chromatographic challenges like carryover, peptide loss during chromatographic run and adsorption of the drug onto the walls of the storage container. This article presents an easy, accurate and reproducible stability-indicating, mass compatible Reverse Phase-Liquid Chromatographic method for the detection of liraglutide in bulk active pharmaceutical ingredient. The stress conditions chosen for the study (hydrolytic, oxidative, photolytic and thermal) were as per the International Council for Harmonization guideline. Chromatographic separation of liraglutide from its degradation products was achieved on a bioZen™ 2.6 μm Peptide XB-C18 100 Å, liquid chromatography column 150×4.6 mm, using ammonium formate buffer (pH 3.0) and acetonitrile (0.1 % formic acid) as the mobile phase in gradient elution mode. The elution was carried out at a flow rate of 0.7 ml/min. Detection of liraglutide and its degradants were monitored at 215 nm. Liraglutide was found to degrade significantly in hydrolytic, oxidative and thermal stress conditions. Apart from stress testing, adsorption study for liraglutide was performed using 5 different types of containers. Also, several buffers/diluents were screened to reduce the carryover of active pharmaceutical ingredient in subsequent chromatographic runs.
Tags from this library: No tags from this library for this title. Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode Item holds
Articles Abstract Database Articles Abstract Database School of Pharmacy
Archieval Section
Not for loan 2024-0416
Total holds: 0

Method development for synthetic peptide molecules is often a challenging task as peptides get easily
degraded in mild stress conditions and also offer chromatographic challenges like carryover, peptide loss
during chromatographic run and adsorption of the drug onto the walls of the storage container. This article
presents an easy, accurate and reproducible stability-indicating, mass compatible Reverse Phase-Liquid
Chromatographic method for the detection of liraglutide in bulk active pharmaceutical ingredient. The stress
conditions chosen for the study (hydrolytic, oxidative, photolytic and thermal) were as per the International
Council for Harmonization guideline. Chromatographic separation of liraglutide from its degradation
products was achieved on a bioZen™ 2.6 μm Peptide XB-C18 100 Å, liquid chromatography column 150×4.6
mm, using ammonium formate buffer (pH 3.0) and acetonitrile (0.1 % formic acid) as the mobile phase in
gradient elution mode. The elution was carried out at a flow rate of 0.7 ml/min. Detection of liraglutide and its
degradants were monitored at 215 nm. Liraglutide was found to degrade significantly in hydrolytic, oxidative
and thermal stress conditions. Apart from stress testing, adsorption study for liraglutide was performed
using 5 different types of containers. Also, several buffers/diluents were screened to reduce the carryover of
active pharmaceutical ingredient in subsequent chromatographic runs.

There are no comments for this item.

Log in to your account to post a comment.

Click on an image to view it in the image viewer

Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.

Powered by Koha